Clinical trial
A Study to Assess the Clinical and Cost-effectiveness of the Galen Prostate Artificial Intelligence Histology System in Diagnosing Clinically Important Prostate Cancer on Prostate Biopsy Tissue.
NCT05228197 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study to Assess the Clinical and Cost-effectiveness of the Galen Prostate Artificial Intelligence Histology System in Diagnosing Clinically Important Prostate Cancer on Prostate Biopsy Tissue.
- Lead sponsor
- Imperial College London
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- March 11, 2022
- Completion date
- April 30, 2025
- Enrollment
- 750 (estimated)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.